Back

Periprocedural, early, and late outcomes following transcatheter aortic valve replacement in patients with severe aortic atheroma

29 August 2025 (11:05 - 11:15)
Organised by: Logo
Congress Presentation Part of: Predictors of TAVI outcomes Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Shinnosuke Kikuchi

University Hospital of Strasbourg, Strasbourg (France)

5 More presentations in this session

Presentation thumbnail
Improving risk stratification in TAVI: the role of epicardial fat, visceral fat and adiponectin
Doctor T. Storozhenko (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and predictors of mortality in TAVI patients with high, low and very low baseline gradient. Analysis of the Spanish TAVI registry
Doctor J. De La Torre Hernandez (Santander, ES)
Abstract Slides Video
Presentation thumbnail
A geriatric assessment score for predicting one-year survival after transcatheter aortic valve implantation: the multicenter GASS-TAVI study
Doctor C. Fumagalli (Naples, IT)
Abstract Slides Video
Presentation thumbnail
Impact of conduction disturbances persistency on 2-year outcomes after transcatheter aortic valve implantation
Doctor S. Okita (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Skirted prosthetic valves are associated with increased risk of subclinical leaflet thrombosis following transcatheter aortic valve replacement: a multicenter study
Doctor Y. Yang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Predictors of TAVI outcomes
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 11:05 CET
You may be interested in
thumbnail
Congress Presentation
Impact of protruding and ulcerated aortic atheroma on periprocedural ischemic stroke in patients undergoing transcatheter aortic valve replacement: a comprehensive analysis
thumbnail
Congress Session
Predictors of TAVI outcomes
thumbnail
Congress Presentation
Prognostic significance of coexistent coronary artery disease in patients undergoing transcatheter aortic valve implantation for aortic stenosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources